Side Effects of COVID-19 Vaccination Among Healthcare Workers in Tehran, Iran Side effects after COVID-19 vaccination
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 13 No. 3 (2023),
17 October 2023
https://doi.org/10.32598/ijmtfm.v13i3.40536
Abstract
Background: Since the emergence of coronavirus disease 2019 (COVID-19), many people have been vaccinated worldwide. Despite the preventive role of vaccines, their side effects face disease management with challenges. This study aims to investigate the side effects of COVID-19 vaccination among healthcare workers in Tehran, Iran.
Methods: This cross-sectional study was conducted from April to October 2022 on 377 healthcare workers in Tehran, Iran. Data collection was carried out through an interview by a researcher using a checklist assessing systemic and local side effects of COVID-19 vaccines.
Results: The mean age of participants was 36.03±10.24 years, and 68.2% were female. Participants experienced significantly more local (26.5% vs. 14.3%, P<0.001) and systemic (52.0% vs. 31.8%, P<0.001) side effects after the first dose than after the second dose. After the first dose, AstraZeneca (45.9%) caused significantly more local reactions than Sputnik V (21.7%) and Sinopharm (14.5%). AstraZeneca (83.7%) caused significantly more systemic side effects than Sputnik V (50.7%) and Sinopharm (14.5%). The prevalence of local and systemic side effects after the first dose was significantly different in terms of vaccine types (P<0.001). After the second dose, AstraZeneca (20.4%) caused significantly more local reactions than Sputnik V (12.8%) and Sinopharm (10.5%) (P<0.001). Additionally, AstraZeneca (38.8%) and Sputnik V (37.4%) caused significantly more systemic side effects than Sinopharm (7.9%) (P<0.001).
Conclusion: Most healthcare workers in Tehran experienced flu-like symptoms and local reactions at the injection site after vaccination against COVID-19, mainly after the first dose. They had more side effects after vaccination with AstraZeneca and Sputnik V, compared to Sinopharm.
- Adverse effects
- COVID-19 vaccines
- Iran
- Safety
- SARS-CoV-2
- 09/30/2023 (2)
- 09/30/2023 (1)
How to Cite
References
Fattahi P, Abdi S, Saeedi E, Sirous S, Firuzian F, Mohammadi M, et al. In-hospital mortality of COVID-19 in Iranian children and youth: A multi-centre retrospective cohort study. Journal of Global Health. 2022; 12:05048. [DOI:10.7189/jogh.12.05048] [PMID] [PMCID]
Galanis P, Vraka I, Katsiroumpa A, Siskou O, Konstantakopoulou O, Katsoulas T, et al. COVID-19 vaccine uptake among healthcare workers: A systematic review and meta-analysis. Vaccines. 2022; 10(10):1637. [DOI:10.3390/vaccines10101637] [PMID] [PMCID]
Yajada M, Karimi Moridani M, Rasouli S. Mathematical model to predict COVID-19 mortality rate. Infectious Disease Modelling. 2022; 7(4):761-76. [DOI:10.1016/j.idm.2022.11.005] [PMID] [PMCID]
Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2020; 508:254-66. [DOI:10.1016/j.cca.2020.05.044] [PMID] [PMCID]
Choi KA, Rezaei M. Assessing the role of urban green areas for students’ quality of life during the covid-19 pandemic. Iranian Journal of Public Health. 2022; 51(5):1049-56. [DOI:10.18502/ijph.v51i5.9420]
Abdolmaleki G, Taheri MA, Paridehpour S, Mohammadi NM, Tabatabaei YA, Mousavi T, et al. A comparison between SARS-CoV-1 and SARS-CoV2: An update on current COVID-19 vaccines. Daru. 2022; 30(2):379-406. [DOI:10.1007/s40199-022-00446-8] [PMID] [PMCID]
Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: Viruses, vaccines and variants versus efficacy, effectiveness and escape. Nature Reviews Immunology. 2021; 21(10):626-36. [DOI:10.1038/s41577-021-00592-1] [PMID] [PMCID]
Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review. Clinical Microbiology and Infection. 2022; 28(2):202-21. [DOI:10.1016/j.cmi.2021.10.005] [PMID] [PMCID]
Sharif N, Alzahrani KJ, Ahmed SN, Dey SK. Efficacy, immunogenicity and safety of covid-19 vaccines: A systematic review and meta-analysis. Frontiers in Immunology. 2021; 12:714170. [DOI:10.3389/fimmu.2021.714170] [PMID] [PMCID]
Lazarus JV, Wyka K, White TM, Picchio CA, Rabin K, Ratzan SC, et al. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nature Communications. 2022; 13(1):3801. [DOI:10.1038/s41467-022-31441-x] [PMID] [PMCID]
Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021; 194:245-51. [DOI:10.1016/j.puhe.2021.02.025] [PMID] [PMCID]
No author. COVID-19 claims 35 more lives as pandemic resurges in Iran [Internet] 2022 [updated 2023 December]. Available from: [Link]
Kamali K, Hoseinzade Z, Hajimiri K, Hoveidamanesh S, Zahraei SM, Gouya MM, et al. Determinants of COVID-19 vaccine acceptance in healthcare workers in Iran: National Survey. BMC Infectious Diseases. 2022; 22(1):703. [DOI:10.1186/s12879-022-07675-x] [PMID] [PMCID]
Babaee E, Amirkafi A, Tehrani-Banihashemi A, SoleimanvandiAzar N, Eshrati B, Rampisheh Z, et al. Adverse effects following COVID-19 vaccination in Iran. BMC Infectious Diseases. 2022; 22(1):476. [DOI:10.1186/s12879-022-07411-5] [PMID] [PMCID]
Al Khames Aga QA, Alkhaffaf WH, Hatem TH, Nassir KF, Batineh Y, Dahham AT, et al. Safety of COVID-19 vaccines. Journal of Medical Virology. 2021; 93(12):6588-94. [DOI:10.1002/jmv.27214] [PMID] [PMCID]
Omeish H, Najadat A, Al-Azzam S, Tarabin N, Abu Hameed A, Al-Gallab N, et al. Reported COVID-19 vaccines side effects among Jordanian population: A cross sectional study. Human Vaccines & Immunotherapeutics. 2022; 18(1):1981086. [DOI:10.1080/21645515.2021.1981086] [PMID] [PMCID]
El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM, Eid B, Almukadi H, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi Residents: A retrospective cross-sectional study. International Journal of General Medicine. 2021; 14:1389-401. [DOI:10.2147/IJGM.S310497] [PMID] [PMCID]
Saeed BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO. Side effects and perceptions following Sinopharm COVID-19 vaccination. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases. 2021; 111:219-26. [DOI:10.1016/j.ijid.2021.08.013] [PMID] [PMCID]
Alhazmi A, Alamer E, Daws D, Hakami M, Darraj M, Abdelwahab S, et al. Evaluation of side effects associated with covid-19 vaccines in Saudi Arabia. Vaccines. 2021; 9(6):674.[DOI:10.3390/vaccines9060674] [PMID] [PMCID]
Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. Journal of Clinical Medicine. 2021; 10(7):1428. [DOI:10.3390/jcm10071428] [PMID] [PMCID]
Elnaem MH, Mohd Taufek NH, Ab Rahman NS, Mohd Nazar NI, Zin CS, Nuffer W, et al. COVID-19 vaccination attitudes, perceptions, and side effect experiences in Malaysia: Do age, gender, and vaccine type matter? Vaccines. 2021; 9(10):1156. [DOI:10.3390/vaccines9101156] [PMID] [PMCID]
Xiong X, Yuan J, Li M, Jiang B, Lu ZK. Age and gender disparities in adverse events following covid-19 vaccination: Real-World evidence based on big data for risk management. Frontiers in Medicine. 2021; 8:700014. [DOI:10.3389/fmed.2021.700014] [PMID] [PMCID]
Alemayehu A, Demissie A, Yusuf M, Abdullahi Y, Abdulwehab R, Oljira L, et al. COVID-19 vaccine side effect: Age and gender disparity in adverse effects following the first dose of AstraZeneca COVID-19 vaccine among the vaccinated population in Eastern Ethiopia: A community-based study. SAGE Open Medicine. 2022; 10:20503121221108616. [DOI:10.1177/20503121221108616]
Riad A, Sağıroğlu D, Üstün B, Pokorná A, Klugarová J, Attia S, et al. Prevalence and risk factors of coronavac side effects: An independent cross-sectional study among healthcare workers in Turkey. Journal of Clinical Medicine. 2021; 10(12):2629. [DOI:10.3390/jcm10122629] [PMID] [PMCID]
Babamahmoodi F, Saeedi M, Alizadeh-Navaei R, Hedayatizadeh-Omran A, Mousavi SA, Ovaise G, et al. Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran. Scientific Reports. 2021; 11(1):21464. [DOI:10.1038/s41598-021-00963-7] [PMID] [PMCID]
Mohammed RA, Garout RM, Wahid S, Ayub F, Firas ZinAlddin LM, Sultan I. A survey on the side effects of Pfizer/BioNTech COVID-19 Vaccine among vaccinated adults in Saudi Arabia. Cureus. 2021; 13(11):e19222. [DOI:10.7759/cureus.19222]
Supangat, Sakinah EN, Nugraha MY, Qodar TS, Mulyono BW, Tohari AI. COVID-19 Vaccines Programs: Adverse events following immunization (AEFI) among medical Clerkship Student in Jember, Indonesia. BMC Pharmacology & Toxicology. 2021; 22(1):58. [DOI:10.1186/s40360-021-00528-4] [PMID] [PMCID]
Abdel-Qader DH, Abdel-Qader H, Silverthorne J, Kongkaew C, Al Meslamani AZ, Hayajneh W, et al. Active safety surveillance of four types of covid-19 vaccines: A national study from Jordan. Clinical Drug Investigation. 2022; 42(10):813-27. [DOI:10.1007/s40261-022-01191-1] [PMID] [PMCID]
Lounis M, Rais MA, Bencherit D, Aouissi HA, Oudjedi A, Klugarová J, et al. Side effects of covid-19 inactivated Virus vs. Adenoviral vector vaccines: Experience of Algerian Healthcare Workers. Frontiers in Public Health. 2022; 10:896343. [DOI:10.3389/fpubh.2022.896343] [PMID] [PMCID]
Greenhawt M, Abrams EM, Shaker M, Chu DK, Khan D, Akin C, et al. The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: A systematic review, meta-analysis, GRADE assessment, and international consensus approach. The Journal of Allergy and Clinical Immunology In Practice. 2021; 9(10):3546-67. [DOI:10.1016/j.jaip.2021.06.006] [PMID] [PMCID]
Hwang I, Park K, Kim TE, Kwon Y, Lee YK. COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021. Osong Public Health and Research Perspectives. 2021; 12(6):396-402. [DOI:10.24171/j.phrp.2021.0310] [PMID] [PMCID]
- Abstract Viewed: 518 times
- pdf Downloaded: 492 times